<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14811-bib-0014">
 <label>14</label>
 <mixed-citation publication-type="journal" id="cas14811-cit-0014">
  <string-name>
   <surname>Araki</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Takashima</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Hamaguchi</surname>
   <given-names>T</given-names>
  </string-name>, et al. 
  <article-title>Amrubicin in patients with platinum‐refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract</article-title>. 
  <source xml:lang="en">Anticancer Drugs</source>. 
  <year>2016</year>;
  <volume>27</volume>:
  <fpage>794</fpage>‐
  <lpage>799</lpage>.
  <pub-id pub-id-type="pmid">27341105</pub-id>
 </mixed-citation>
</ref>
